Literature DB >> 18202698

Translation of new cancer treatments from pet dogs to humans.

Melissa Paoloni1, Chand Khanna.   

Abstract

Naturally occurring cancers in pet dogs and humans share many features, including histological appearance, tumour genetics, molecular targets, biological behaviour and response to conventional therapies. Studying dogs with cancer is likely to provide a valuable perspective that is distinct from that generated by the study of human or rodent cancers alone. The value of this opportunity has been increasingly recognized in the field of cancer research for the identification of cancer-associated genes, the study of environmental risk factors, understanding tumour biology and progression, and, perhaps most importantly, the evaluation and development of novel cancer therapeutics.

Entities:  

Mesh:

Year:  2008        PMID: 18202698     DOI: 10.1038/nrc2273

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  239 in total

1.  Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.

Authors:  K A Skorupski; T G O'Brien; T Guerrero; C O Rodriguez; M R Burns
Journal:  Vet Comp Oncol       Date:  2011-03-08       Impact factor: 2.613

2.  Evidence of an oncogenic gammaherpesvirus in domestic dogs.

Authors:  Shih-Hung Huang; Philip J Kozak; Jessica Kim; Georges Habineza-Ndikuyeze; Charles Meade; Anita Gaurnier-Hausser; Reema Patel; Erle Robertson; Nicola J Mason
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

Review 3.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

Review 4.  Defining the Value of a Comparative Approach to Cancer Drug Development.

Authors:  Amy K LeBlanc; Christina N Mazcko; Chand Khanna
Journal:  Clin Cancer Res       Date:  2015-12-28       Impact factor: 12.531

5.  Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.

Authors:  Sandra M Axiak-Bechtel; Senthil R Kumar; Kristin K Dank; Nicole A Clarkson; Kim A Selting; Jeffrey N Bryan; Thomas J Rosol; Jahna Espinosa; Charles J Decedue
Journal:  Invest New Drugs       Date:  2013-09-13       Impact factor: 3.850

6.  Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.

Authors:  Nicholas J Andersen; Brian J Nickoloff; Karl J Dykema; Elissa A Boguslawski; Roman I Krivochenitser; Roe E Froman; Michelle J Dawes; Laurence H Baker; Dafydd G Thomas; Debra A Kamstock; Barbara E Kitchell; Kyle A Furge; Nicholas S Duesbery
Journal:  Mol Cancer Ther       Date:  2013-06-26       Impact factor: 6.261

7.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

8.  The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.

Authors:  Katerina Angelopoulou; George S Karagiannis
Journal:  Mamm Genome       Date:  2009-12-02       Impact factor: 2.957

9.  Copy number abnormalities in sporadic canine colorectal cancers.

Authors:  Jie Tang; Shoshona Le; Liang Sun; Xiuzhen Yan; Mucheng Zhang; Jennifer Macleod; Bruce Leroy; Nicole Northrup; Angela Ellis; Timothy J Yeatman; Yanchun Liang; Michael E Zwick; Shaying Zhao
Journal:  Genome Res       Date:  2010-01-19       Impact factor: 9.043

10.  Toward a drug development path that targets metastatic progression in osteosarcoma.

Authors:  Chand Khanna; Timothy M Fan; Richard Gorlick; Lee J Helman; Eugenie S Kleinerman; Peter C Adamson; Peter J Houghton; William D Tap; Danny R Welch; Patricia S Steeg; Glenn Merlino; Poul H B Sorensen; Paul Meltzer; David G Kirsch; Katherine A Janeway; Brenda Weigel; Lor Randall; Stephen J Withrow; Melissa Paoloni; Rosandra Kaplan; Beverly A Teicher; Nita L Seibel; Malcolm Smith; Aykut Uren; Shreyaskumar R Patel; Jeffrey Trent; Sharon A Savage; Lisa Mirabello; Denise Reinke; Donald A Barkaukas; Mark Krailo; Mark Bernstein
Journal:  Clin Cancer Res       Date:  2014-05-06       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.